GSK

MHRA okays GSK’s Xevudy as data suggest it works against Omicron
Pharmaforum
Thu, 12/2/21 - 10:51 am
GSK
UK
MHRA
Xevudy
Vir Biotechnology
COVID-19
Omicron COVID-19 variant
GSK unveils Target the Future, a global, multi-year program to help address key challenges affecting the multiple myeloma community
Indiana Gazette
Wed, 12/1/21 - 11:44 pm
GSK
Target the Future
Multiple Myeloma
Get ready for M&A: Large biopharma companies will have $1.7T in dealmaking firepower next year, analyst says
Fierce Pharma
Wed, 12/1/21 - 11:28 am
M&A
pharma industry
Big Pharma
JNJ
Pfizer
Moderna Therapeutics
Novartis
BioNTech
GSK
GSK's ViiV looks to future of injectable HIV treatment as long-acting PrEP decision looms
Fierce Pharma
Tue, 11/30/21 - 11:24 pm
ViiV Healthcare
GSK
HIV
PrEP
cabotegravir
GlaxoSmithKline poaches Pfizer vax leader Dormitzer after hemorrhaging vaccine R&D talent
Fierce Biotech
Tue, 11/30/21 - 10:42 am
GSK
Pfizer
vaccines
R&D
COVID-19
GlaxoSmithKline takes aim at NASH, penning a $1B pact with RNAi biotech Arrowhead
Fierce Biotech
Mon, 11/22/21 - 10:19 pm
GSK
Arrowhead Pharmaceuticals
NASH
RNAi
GlaxoSmithKline, Vir target emergency authorization for intramuscular COVID-19 antibody drug with new trial win
Fierce Pharma
Sat, 11/13/21 - 09:47 pm
GSK
Vir Biotechnology
antibodies
COVID-19
drug delivery
GSK's ViiV turns to Black women's experiences in latest season of award-winning podcast
Fierce Pharma
Tue, 11/9/21 - 10:35 am
GSK
ViiV Healthcare
HIV
AIDS
podcasts
pharma marketing
GSK pulls off clean sweep of endpoint hits in anemia phase 3, positioning it to leapfrog AstraZeneca
Fierce Biotech
Mon, 11/8/21 - 10:47 am
GSK
chronic kidney disease
cliincal trials
FDA
AstraZeneca
anemia
erythropoietin
FibroGen
Acquisition Rumors Continue to Circulate Around Aurinia as GSK Denies Interest
BioSpace
Mon, 11/1/21 - 11:21 pm
GSK
Aurinia Pharmaceuticals
M&A
GSK, after pushing past midphase fail, ends development of otilimab in COVID-19
Fierce Biotech
Wed, 10/27/21 - 11:01 am
GSK
otilimab
COVID-19
clinical trials
The biotech behind GlaxoSmithKline's PD-1 just scored a $250M cash deal for royalties
Endpoints
Tue, 10/26/21 - 10:46 am
AnaptysBio
Jemperli
GSK
GSK tangoes with private equity players to explore $54B sale of consumer unit instead of IPO — report
Endpoints
Wed, 10/13/21 - 11:08 am
GSK
spinoff
consumer health
private equity
CureVac drops COVID-19 vaccine candidate; shifts focus to second-generation mRNA program
Biopharma Reporter
Tue, 10/12/21 - 11:06 am
CureVac
vaccines
COVID-19
MRNA
GSK
GSK Continues to Switch Up Scenery in Advance of Upcoming Demerger
BioSpace
Mon, 10/11/21 - 09:55 pm
GSK
headquarters
GSK and Vir turn to US for distribution as Covid-19 mAb treatment nears blockbuster status
Endpoints
Mon, 10/11/21 - 09:50 pm
GSK
Vir Biotechnology
COVID-19
monoclonal antibodies
Sanofi, GSK, Pfizer and Boehringer must face Zantac class-action lawsuits, court rules
Fierce Pharma
Fri, 10/8/21 - 11:00 am
GSK
Sanofi
Pfizer
Boehringer Ingelheim
legal
class action lawsuits
Zantac
Pilot launch complete: GlaxoSmithKline's malaria shot scores WHO backing for wider rollout in Africa
Fierce Pharma
Wed, 10/6/21 - 11:24 pm
GSK
vaccines
malaria
WHO
RTS
S
Pharma giant GSK is leaving Research Triangle Park and relocating to downtown Durham
News and Observer, NC
Tue, 10/5/21 - 10:40 am
GSK
RTP
relocation
remote work
GSK's $4.2B bet on Merck KGaA's cancer drug goes up in smoke as pharmas cut ties after series of flops
Fierce Biotech
Thu, 09/30/21 - 10:58 pm
GSK
Merck KGaA
oncology
cancer
biliary tract cancer

Pages